In Defense of Avandia (rosiglitazone) Hal Roseman, MD, MPH, FACC, FACP 1

First Page		Document Content
Chemistry Organic chemistry Medicine GlaxoSmithKline Rosiglitazone Eli Lilly and Company Pioglitazone Metformin Sulfonylurea Thiazolidinediones Pyridines Diabetes		In Defense of Avandia (rosiglitazone) Hal Roseman, MD, MPH, FACC, FACP 1 Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 1,44 MB Share Document on Facebook

	C:uments and Settingsyandktoprmacists Bulletin July 2015.wpd DocID: 1qQog - View Document
	The n e w e ng l a n d j o u r na l of DocID: 1pznD - View Document
	SPECIAL AUTHORIZATION REQUEST DPP-4/SGLT2 INHIBITORS Fax requests toOR mail requests to PEI Pharmacare, P.O. Box 2000, Charlottetown, PE, C1A 7N8 SECTION 1 – PRESCRIBER INFORMATION DocID: 1pr3h - View Document
	Official Newsletter of the Utah Poison Control Center 2010 • VOLUME 12 • ISSUE 4 T O D A Y NEW DRUGS FOR TREATMENT OF DIABETES DocID: 1oY1K - View Document
	Victoza (liraglutide [rDNA origin] injection DocID: 1nE7h - View Document